Skip to main content
MedPath Trial logoMedPath TrialMedPath Trial Home
Clinical Trials/CTRI/2022/10/046353
CTRI/2022/10/046353Recruiting未知

A randomized double-blind placebo controlled clinical study for the comparative evaluation of efficacy and tolerability of commercial extract of Boswellia serrata in improving knee joint health in adult subjects with non/mild osteoarthritis

Daehan chemtech co.,Ltd0 sites0 target enrollmentStarted: TBDLast updated:
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit

Trial Snapshot

Phase
未知
Status
Recruiting
Sponsor
Study OverviewEligibility CriteriaInvestigatorsRecords & IdentifiersSimilar Trials

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Inclusion Criteria

  • •1. Ambulatory, male and female subjects 40 to 75 years of age.
  • •2. KL (Kellgren Lawrence) grade of 0 to 2.
  • •3. At least 30 on 100mm visual analogue scale.
  • •4. Subjects having mild-to-moderate pain in knee joint upon completion of 30 sec Chair Stand Test or 80 meter Fast-Paced Walk Test, and otherwise no knee pain at rest.
  • •5. Subjects willing to refrain from taking Ibuprofen, Aspirin or other NSAIDS or any other pain reliever (OTC or prescription) during the entire trial.
  • •6. Subjects willing to sign the informed consent and comply with study procedure

Exclusion Criteria

  • •1. Subjects with any possible signs / indication / history of arthritis, joint disorders including dislocations and quadriceps tendons tear.
  • •2. Subjects with history of underlying inflammatory arthropathy or severe RA or OA.
  • •3. Subjects having used any immunosuppressive drugs in the last 6 months (including steroids or biologics) and those with history of immune system and autoimmune disorders.
  • •4. Subjects with a history of knee or hip joint replacement surgery, or any hip or back pain which interferes with ambulation.
  • •5. Subjects with BMI less than 18.5 or more than 30.
  • •6. Subjects who consumed the medicines or supplements related with joint health within 30 days before screening visit.
  • •7. Subjects who are not acceptable for the test by the judgment of PI.
  • •8. Subjects with the history of tobacco smoking.
  • •9. Subjects expecting the surgery during the study duration period.
  • •10. Female subjects, who are pregnant, breast feeding or planning to become pregnant.
  • •11. Subjects having known allergy to non-steroidal anti-inflammatory drugs (NSAIDs) (including aspirin) or has a suspected hypersensitivity, allergy or sensitivity to herbal products.
  • •12. Subjects who have any physical disability which could interfere with their ability to perform the functional performance measures included in this protocol.
  • •13. Subjects with history of gout.
  • •14. Subjects who have taken corticosteroid, indomethacin, glucosamine+ chondroitin, within 90 days prior to the screening visit or intra-articular treatment / injections with corticosteroid or hyaluronic acid within 90 days preceding the screening visit.
  • •15. Subjects with the history of congestive heart failure or any vascular conditions.
  • •16. Subjects with the evidence or history of clinically significant (in the judgment of the Investigator) haematological, renal, endocrine, pulmonary, gastrointestinal, cardiovascular, hepatic or neurologic diseases, or malignancies, hypothyroidism.
  • •17. History of Systemic Lupus Erythematous (SLE).
  • •18. High alcohol intake ( >2 standard drinks per day).
  • •19. History of psychiatric disorder that may impair the ability of subjects to provide written informed consent.
  • •20. Participation in any other trials involving investigational or marketed products within 90 days prior to the screening visit.
  • •21. Subjects who have consumed Acetaminophen / Paracetamol, Ibuprofen, Aspirin or other NSAIDS or any other pain reliever (OTC or prescription) or any natural health product, (excluding vitamins), within 30 days prior to the screening visit.

Investigators

Sponsor
Daehan chemtech co.,Ltd

Similar Trials

Recruiting
Phase 3
Clinical study on knee joint health in adult subjects
CTRI/2024/02/062580Daehan Chemtech Co Ltd
Completed
Phase 4
A Clinical trail to see the effect of Probiotics and Docosahexaneoic Acid on learning ability, memory and behavior in Children Aged 7â??13 Years
CTRI/2016/12/007537Department of Health Research840
Recruiting
Phase 3
Clinical study on knee joint health in adult subjects.
CTRI/2024/02/062371Daehan Chemtech Co Ltd
Recruiting
Phase 2
Homeopathic treatment of nicotine dependence
CTRI/2018/04/013329ational Institute of Homoeopathy Ministry of AYUSH Govt of India
Recruiting
Phase 2
Homeopathic treatment of knee osteoarthritis
CTRI/2018/04/013342ational Institute of Homoeopathy Ministry of AYUSH Govt of India